PSPaola Salvatore

Paola Salvatore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paola Salvatore has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Mauricio Tohen

    International Consortium for Mood and Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts

    10 shared publications
  • Ross J. Baldessarini

    International Consortium for Mood and Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts

    10 shared publications
  • Carlo Maggini

    International Consortium for Mood and Psychotic Disorders Research, McLean Hospital, Belmont, Massachusetts, USA

    8 shared publications
  • Ross J. Baldessarini

    Department of Psychiatry Harvard Medical School Boston Massachusetts USA

    5 shared publications
  • Hari-Mandir K. Khalsa

    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

    4 shared publications
  • Harimandir K. Khalsa

    International Consortium for Mood and Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts

    4 shared publications

Latest Publications

  • Suicide Attempts in First Episodes of Major Psychiatric Disorders With Psychotic Features

    by Paola Salvatore, Harimandir K. Khalsa, Ross J. Baldessarini, Mauricio Tohen

    Suicidal behavior is prevalent with first psychotic episodes, but reports of associated factors involve inconsistent findings and emphasis on schizophrenia. We evaluated suicide attempt rates and associated risk factors in 395 first-episode patients with various DSM-5-TR diagnoses with psychotic features, comparing 83 suicidal patients to others. Suicide attempt risk averaged 21.0%, with the final diagnosis ranked as follows: major depression, bipolar I depression, bipolar I mixed features, schizoaffective—depressed, unspecified psychosis, schizophrenia, schizoaffective—bipolar, bipolar I mania, delusional disorder, and none with schizophreniform or brief psychosis. Associated by multivariable modeling were initial recklessness ≥ initial impulsive violence ≥ initial anergy ≥ prior suicide attempt ≥ initial despair ≥ initially homicidal. Risk factors were similar in 36.1% of suicidal cases before and at first episodes. Suicide attempts were prevalent with hospitalized first psychotic episodes: more with major affective disorders or schizoaffective—depression than with schizophrenia or other diagnoses. Notable risk factors included initial reckless, impulsive, angry, and violent behavior, depressive features, anergy, and prolonged prodromes.

  • Circadian Activity Rhythms and Psychopathology in Major Depressive Episodes

    by Paola Salvatore, Premananda Indic, Harimandir K. Khalsa, Mauricio Tohen, Ross J. Baldessarini, Carlo Maggini

    Background: Identifying suicidal risk based on clinical assessment is challenging. Suicidal ideation fluctuates, can be downplayed or denied, and seems stigmatizing if divulged. In contrast, vitality is foundational to subjectivity in being immediately conscious before reflection. Including its assessment may improve detection of suicidal risk compared to relying on suicidal ideation alone. We hypothesized that objective motility measures would be associated with vitality and enhance assessment of suicidal risk. Methods: We evaluated 83 adult-psychiatric outpatients with a DSM-5 bipolar (BD) or major depressive disorder (MDD): BD-I (n = 48), BD-II (20), and MDD (15) during a major depressive episode. They were actigraphically monitored continuously over 3 weekdays and self-rated their subjective states at regular intervals. We applied cosinor analysis to actigraphic data and analyzed associations of subjective psychopathology measures with circadian activity parameters. Results: Actigraphic circadian mesor, amplitude, day- and nighttime activity were lower with BD versus MDD. Self-rated vitality (wish-to-live) was significantly lower, self-rated suicidality (wish-to-die) was higher, and their difference was lower, with BD versus MDD. There were no other significant diagnostic differences in actigraphic sleep parameters or in self-rated depression, dysphoria, or anxiety. By linear regression, the difference between vitality and passive suicidal ideation was strongly positively correlated with mesor (p < 0.0001), daytime activity (p < 0.0001), and amplitude (p = 0.001). Conclusions: Higher circadian activity measures reflected enhanced levels of subjective vitality and were associated with lesser suicidal ideation. Current suicidal-risk assessment might usefully include monitoring of motility and vitality in addition to examining negative affects and suicidal thinking.


  • Open Access

    Factors associated with onset‐age in major affective disorders

    by Alessandro Miola, Leonardo Tondo, Paola Salvatore, Ross J. Baldessarini

    Background: Research findings on factors associated with onset‐age (OA) with bipolar (BD) and major depressive disorders (MDD) have been inconsistent, but often indicate greater morbidity following early OA.Methods: We considered factors associated with OA in 1033 carefully evaluated, systematically followed mood disorder subjects with DSM‐5 BD (n = 505) or MDD (n = 528), comparing rates of descriptive and clinical characteristics following early (age <18), intermediate (18–40), or later onset (≥40 years), as well as regressing selected measures versus OA. Exposure time (years ill) was matched among these subgroups.Results: As hypothesized, many features were associated with early OA: familial psychiatric illness, including BD, greater maternal age, early sexual abuse, nondepressive first episodes, co‐occurring ADHD, suicide attempts and violent suicidal behavior, abuse of alcohol or drugs, smoking, and unemployment. Other features increased consistently with later OA: %‐time‐depressed (in BD and MDD, women and men), as well as depressions/year and intake ratings of depression, educational levels, co‐occurring medical disorders, rates of marriage and number of children.Conclusions: OA averaged 7.5 years earlier in BD versus MDD (30.7 vs. 38.2). Some OA‐associated measures may reflect maturation. Associations with family history and suicidal risk with earlier OA were expected; increases of time‐depressed in both BD and MDD with later OA were not. We conclude that associations of OA with later morbidity are complex and not unidirectional but may be clinically useful.


  • Prodromal features in first-psychotic episodes of major affective and schizoaffective disorders

    by Paola Salvatore, Ross J. Baldessarini, Harimandir K. Khalsa, Mauricio Tohen


  • Long‐term morbidity in major affective and schizoaffective disorders following hospitalization in first psychotic episodes

    by Paola Salvatore, Harimandir K. Khalsa, Mauricio Tohen, Ross J. Baldessarini

    Objective: To evaluate morbidity during long‐term follow‐up with clinical treatment of affective and schizoaffective disorder subjects followed from hospitalization for first major psychotic episodes.Methods: We followed adult subjects systematically at regular intervals from hospitalization for first‐lifetime episodes of major affective and schizoaffective disorders with initial psychotic features. We compiled % of days with morbidity types from detailed records and life charts, reviewed earliest antecedent morbidities, compared both with final diagnoses and initial presenting illness types, and evaluated morbidity risk factors with regression modeling.Findings: With final diagnoses of bipolar‐I (BD‐I, n = 216), schizoaffective (SzAffD, 71), and major depressive (MDD, 42) disorders, 329 subjects were followed for 4.47 [CI: 4.20–4.47] years. Initial episodes were mania (41.6%), mixed states (24.3%), depression (19.5%), or apparent nonaffective psychosis (14.6%). Antecedent morbidity presented 12.7 years before first episodes (ages: SzAffD ≤ BD‐I < MDD). Long‐term % of days ill ranked SzAffD (83.0%), MDD (57.8%), BD‐I (45.0%). Morbidity differed by diagnosis and first‐episode types, and was predicted by first episodes and suggested by antecedent illnesses. Long‐term wellness was greater with BD‐I diagnosis, first episode not mixed or psychotic nonaffective, rapid onset, and being older at first antecedents, but not follow‐up duration.Conclusions: Initially, psychotic BD‐I, SzAffD, or MDD subjects followed for 4.47 years from first hospitalization experienced much illness, especially depressive or dysthymic, despite ongoing clinical treatment. Antecedent symptoms arose years before index first episodes; antecedents and first episode types predicted types and amounts of long‐term morbidity, which ranked: SzAffD > MDD > BD‐I.


  • Open Access

    Aggression among 216 patients with a first-psychotic episode of bipolar I disorder

    by Hari-Mandir K. Khalsa, Ross J. Baldessarini, Mauricio Tohen, Paola Salvatore

    Aggression by patients with bipolar I disorder (BD-I) is not uncommon. Identifying potential risk factors early in the illness-course should inform clinical management and reduce risk. In a study sample of 216 initially hospitalized, first-psychotic episode subjects diagnosed with DSM-IV-TR BD-I, we identified recent (within 1 month before hospitalization) aggression by ratings on the Brief Psychiatric Rating Scale-Expanded and review of detailed clinical research records. We compared subjects with versus without aggressive behavior for associations with selected demographic and clinical factors. Aggression was identified in 23/216 subjects (10.6%). It was associated significantly with recent suicide attempt (OR = 4.86), alcohol abuse (OR = 3.63), learning disability (OR = 3.14), and initial manic episode (OR = 2.59), but not with age, sex, onset-type, personality disorder, time to recovery, or functional status. Among first-major episode BD-I patients with psychotic features, recent serious aggression towards others was identified in 10.6%. The odds of aggression increased by 4.9-times in association with a recent suicide attempt, more than 3-times with alcohol-abuse or learning disability, and by 2.6-times if the episode polarity was manic. The findings encourage closer management of alcohol misuse, suicide risk, and manic symptoms, and early detection of learning problems in BD-I patients.


  • Comparison of psychotic bipolar disorder, schizoaffective disorder, and schizophrenia: an international, multisite study

    by L. Tondo, G. H. Vázquez, C. Baethge, C. Baronessa, L. Bolzani, A. Koukopoulos, L. Mazzarini, A. Murru, I. Pacchiarotti, M. Pinna, et al.

    Nosological distinctions among schizoaffective disorder (SA), bipolar I disorder with psychotic features (BDp), and schizophrenia (SZ) remain unresolved. We compared 2269 subjects with psychotic features in DSM-IV-TR diagnoses (1435 BDp, 463 SZ, 371 SA) from 8 collaborating international sites, by 12 sociodemographic and clinical measures, all between diagnostic pairs. In bivariate comparisons, SA was consistently intermediate between BDp and SZ for 11/12 features (except onset stressors), and SZ vs. BDp differed in all 12 factors. SA differed from both BDp and SZ in 9/12 factors: SA and BDp were similar in education and suicidal ideation or acts; SA and SZ were similar in education, onset stressors, and substance abuse. Meta-analytic comparisons of diagnostic pairs for 10 categorical factors indicated similar differences of SA from both SZ and BDp. Multivariate modeling indicated significantly independent differences between BDp and SZ (8 factors), SA vs. SZ (5), and BDp vs. SA (3). Measurement variance was similar for all diagnoses. SA was consistently intermediate between BDp and SZ. The three diagnostic groups ranked: BDp > SA > SZ related to lesser morbidity or disability. The findings are not consistent with a dyadic Kraepelinian categorization, although the considerable overlap among the three DSM-IV diagnostic groups indicates uncertain boundaries if they represent distinct disorders.


  • History of Bipolar Manic-Depressive Disorder

    by Ross J. Baldessarini, Jesús Pérez, Paola Salvatore, Katharina Trede, Carlo Maggini

    Melancholia and mania were described by ancient medical scholars, sometimes in the same persons. Linkage of the syndromes continued among Greco-Roman, Persian, and Arabic scholars throughout the first and by Europeans in the second millennium CE. Early terms describing a single disorder can be found in 1684 (Bonet: manico-melancholicus) and 1759 (Piquer-Arrufat: affectio melancholico-maniaca). The concept was reiterated by Falret and Baillarger (1854) and broadened by Kahlbaum and Hecker (cyclothymia). Weygandt described manic and melancholic features within a single episode (mixed states). Kraepelin gathered a range of recurrent, mainly affective disorders into a broad concept (manic-depressive insanity) in 1895, contrasted to chronic psychotic disorders (dementia præcox, later schizophrenia). In the mid-20th century, recurrent (unipolar) major depressions were differentiated from those with manic episodes (bipolar I disorder), encouraged in part by new treatments. A syndrome (bipolar II) involving recurrent depressions and hypomania was added in the 1970s. Bipolar disorder was accepted into international nosology (DSM-III) in 1980. The concept has broadened further to include relatively mild mood fluctuations (cyclothymia), recurrent depression with minor hypomanic features (bipolar spectrum), and proposed bipolar-like pediatric syndromes (juvenile bipolar disorder). Current ferment in psychiatric nosology is driven by uncertainties about limits and subtypes among major affective and psychotic disorders and by the need to confront the “phenotype problem” faced by modern biological and therapeutic research in psychiatry.


  • Capgras' Syndrome in First-Episode Psychotic Disorders

    by Paola Salvatore, Chaya Bhuvaneswar, Mauricio Tohen, Hari-Mandir K. Khalsa, Carlo Maggini, Ross J. Baldessarini

    Background: Misidentification phenomena, including the delusion of ‘imposters' named after Joseph Capgras, occur in various major psychiatric and neurological disorders but have rarely been studied systematically in broad samples of modern patients. This study investigated the prevalence and correlated clinical factors of Capgras' phenomenon in a broad sample of patient-subjects with first-lifetime episodes of psychotic affective and nonaffective disorders. Methods: We evaluated 517 initially hospitalized, first-episode psychotic-disorder patients for the prevalence of Capgras' phenomenon and its association with DSM-IV-TR diagnoses including schizophreniform, brief psychotic, unspecified psychotic, delusional, and schizoaffective disorders, schizophrenia, bipolar-I disorder and major depression with psychotic features, and with characteristics of interest including antecedent psychiatric and neurological morbidity, onset type and presenting psychopathological phenomena, using standard bivariate and multivariate statistical methods. Results: Capgras' syndrome was identified in 73/517 (14.1%) patients (8.2-50% across diagnoses). Risk was greatest with acute or brief psychotic disorders (schizophreniform psychoses 50%, brief psychoses 34.8%, or unspecified psychoses 23.9%), intermediate in major depression (15%), schizophrenia (11.4%) and delusional disorder (11.1%), and lowest in bipolar-I (10.3%) and schizoaffective disorders (8.2%). Associated were somatosensory, olfactory and tactile hallucinations, Schneiderian (especially delusional perception), and cycloid features including polymorphous psychotic phenomena, rapidly shifting psychomotor and affective symptoms, pananxiety, ecstasy, overconcern with death, and perplexity or confusion, as well as rapid onset, but not sex, age, abuse history, dissociative features, or indications of neurological disorders. Conclusions: Capgras' syndrome was prevalent across a broad spectrum of first-episode psychotic disorders, most often in acute psychoses of rapid onset.


  • Predicting Diagnostic Change Among Patients Diagnosed With First-EpisodeDSM-IV-TRMajor Depressive Disorder With Psychotic Features

    by Paola Salvatore, Ross J. Baldessarini, Hari-Mandir K. Khalsa, Mario Amore, Cristina Di Vittorio, Gabriella Ferraro, Carlo Maggini, Mauricio Tohen

    Longitudinal studies beginning from onset of major depressive disorder (MDD) with psychotic features in young adults are rare; therefore, in this study, subjects across a wide age range were included. Since psychotic MDD may be unstable diagnostically, we systematically evaluated such patients prospectively from first episode to ascertain predictors of later diagnostic change. In this prospective naturalistic study, we recruited patients with DSM-IV-TR psychotic MDD from 1989 through 2003 at psychiatric inpatient units in Massachusetts and Italy and followed them from first hospitalization to compare demographic, antecedent, and first-episode clinical characteristics for associations with later changes of diagnosis based on interviews using the Structured Clinical Interview for DSM-III-R, Patient Version. Within a mean (SD) of 4.0 (2.7) years, diagnoses among 107 subjects aged 34.6 (16.2) years (range, 10-82 years) who were experiencing a first lifetime DSM-IV-TR psychotic MDD episode changed in 29.9% to DSM-IV-TR bipolar disorder (18.7%) or schizoaffective disorder (11.2%). Factors associated with stable diagnoses of psychotic MDD included ontological anguish (χ(2) = 13.8, P < .0001), nihilistic delusions (χ(2) = 4.47, P = .034), and weight loss (χ(2) = 4.69, P = .030) at initial syndromal presentation. Factors preceding diagnoses of bipolar disorder included antecedent impulsivity (χ(2) = 9.10, P = .003), ICD-10 mixed states at intake (χ(2) = 19.4, P < .0001), and previous hypomanic symptoms (χ(2) = 13.7, P = .002). Factors predicting later schizoaffective diagnoses included mood-incongruent delusions (χ(2) = 9.17, P = .002) and somatosensory hallucinations (χ(2) = 9.53, P = .033) at intake, previous functional decline (χ(2) = 8.13, P = .008), initial Schneiderian first-rank symptoms (χ(2) = 10.6, P = .005), and meeting criteria for ICD-10 schizoaffective disorder at intake (χ(2) = 24.9, P < .0001). Among patients who initially met DSM-IV-TR criteria for first-episode psychotic MDD, early indications of features typically associated with bipolar disorder or with nonaffective psychoses, respectively, strongly predicted later diagnostic change to bipolar disorder or schizoaffective disorders. The findings support the value of psychopathological details in improving diagnostic and prognostic criteria for complex illnesses.